Generic Drug Recall Expanded



ETHEX Corp. began a recall of several generic drugs months ago due to a problem in the manufacturing of the drugs made by their parent company KV Pharmaceuticals. This is a precautionary action taken by ETHEX after it was found the drugs were not manufactured under conditions that complied with the FDA’s current Good Manufacturing Practice regulations. This recall was primarily a wholesale level, but has grown to include retail.

The recall began last summer when ETHEX recalled lots of 30 and 60 mg morphine extended release tablets because they were oversized. This was followed by recalls in October, November, and December of other various extended release tablets for the same reasons. Prior to the latest generic drug recall, ETHEX recalled prescription infant vitamins and iron supplements.

The expanded ETHEX Corp. recall includes:

  • Morphine Sulfate Extended-Release Tablets 15 mg, 30 mg and 60mg (all strengths)
  • Morphine Sulfate Immediate-Release Tablets 15 mg and 30 mg (all strengths)
  • Dextroamphetamine Sulfate Tablets 5 mg and 10 mg (all strengths)
  • Isosorbide Mononitrate Extended-Release Tablets 30 mg, 60 mg and 120 mg (all strengths)
  • Propafenone HCl Tablets 150 mg, 22 5mg and 300 mg (all strengths)

Patients who may be taking these products should continue taking them as prescribed, as suddenly quitting a needed medication may put the patient at risk. Patients are also asked to contact their physicians if there are further concerns or questions.

If you or a loved one has been sickened by taking these defective drugs, please contact Personal to find an experienced personal injury lawyer in your area.